132 related articles for article (PubMed ID: 21992555)
1. Effective treatment of diabetes caused by activating ABCC8/SUR1 mutation with glimepiride.
Karges B; Schnur D; Ellard S; Kentrup H; Karges W
Diabet Med; 2012 May; 29(5):692-3. PubMed ID: 21992555
[No Abstract] [Full Text] [Related]
2. [Molecular basis of oral hypoglycemic sulfonylurea action].
Owecki M; Horst-Sikorska W; Sowiński J
Pol Merkur Lekarski; 2003 Nov; 15(89):445-8. PubMed ID: 14969140
[TBL] [Abstract][Full Text] [Related]
3. Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation.
Zwaveling-Soonawala N; Hagebeuk EE; Slingerland AS; Ris-Stalpers C; Vulsma T; van Trotsenburg AS
Diabetologia; 2011 Feb; 54(2):469-71. PubMed ID: 21109997
[No Abstract] [Full Text] [Related]
4. [Three-year observation of permanent neonatal diabetes].
Noczyńska A; Zubkiewicz-Kucharska A; Salmonowicz B; Małecki M; Młynarski W
Pediatr Endocrinol Diabetes Metab; 2010; 16(1):50-4. PubMed ID: 20529607
[TBL] [Abstract][Full Text] [Related]
5. A pathway to insulin independence in newborns and infants with diabetes.
Shahawy S; Chan NK; Ellard S; Young E; Shahawy H; Mace J; Peverini R; Chinnock R; Njolstad PR; Hattersley AT; Hathout E
J Perinatol; 2011 Aug; 31(8):567-70. PubMed ID: 21796147
[TBL] [Abstract][Full Text] [Related]
6. Transient neonatal diabetes due to activating mutation in the ABCC8 gene encoding SUR1.
Batra CM; Gupta N; Atwal G; Gupta V
Indian J Pediatr; 2009 Nov; 76(11):1169-72. PubMed ID: 20092027
[TBL] [Abstract][Full Text] [Related]
7. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.
Oztekin O; Durmaz E; Kalay S; Flanagan SE; Ellard S; Bircan I
J Perinatol; 2012 Aug; 32(8):645-7. PubMed ID: 22842804
[TBL] [Abstract][Full Text] [Related]
8. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
Sperling MA
N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555
[No Abstract] [Full Text] [Related]
9. A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up.
Katanic D; Vorgučin I; Hattersley A; Ellard S; Houghton JAL; Obreht D; Knežević Pogančev M; Vlaški J; Pavkov D
Diabetes Res Clin Pract; 2017 Jul; 129():59-61. PubMed ID: 28511139
[TBL] [Abstract][Full Text] [Related]
10. New ABCC8 mutations in relapsing neonatal diabetes and clinical features.
Vaxillaire M; Dechaume A; Busiah K; Cavé H; Pereira S; Scharfmann R; de Nanclares GP; Castano L; Froguel P; Polak M;
Diabetes; 2007 Jun; 56(6):1737-41. PubMed ID: 17389331
[TBL] [Abstract][Full Text] [Related]
11. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
[TBL] [Abstract][Full Text] [Related]
12. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
[TBL] [Abstract][Full Text] [Related]
13. [Permanent neonatal diabetes with known genetic background: oral drugs in treatment of childhood diabetes].
Gach A; Gadzicka A; Młynarski W
Pediatr Endocrinol Diabetes Metab; 2008; 14(1):45-9. PubMed ID: 18577347
[TBL] [Abstract][Full Text] [Related]
14. ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas.
Sato R; Watanabe H; Genma R; Takeuchi M; Maekawa M; Nakamura H
Pharmacogenomics; 2010 Dec; 11(12):1743-50. PubMed ID: 21142918
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes.
Hartemann-Heurtier A; Simon A; Bellanné-Chantelot C; Reynaud R; Cavé H; Polak M; Vaxillaire M; Grimaldi A
Diabetes Metab; 2009 Jun; 35(3):233-5. PubMed ID: 19342262
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous ABCC8 mutations are a cause of MODY.
Bowman P; Flanagan SE; Edghill EL; Damhuis A; Shepherd MH; Paisey R; Hattersley AT; Ellard S
Diabetologia; 2012 Jan; 55(1):123-7. PubMed ID: 21989597
[TBL] [Abstract][Full Text] [Related]
17. Insulin secretagogues, sulfonylurea receptors and K(ATP) channels.
Bryan J; Crane A; Vila-Carriles WH; Babenko AP; Aguilar-Bryan L
Curr Pharm Des; 2005; 11(21):2699-716. PubMed ID: 16101450
[TBL] [Abstract][Full Text] [Related]
18. Permanent neonatal diabetes caused by a novel mutation.
Jain V; Flanagan SE; Ellard S
Indian Pediatr; 2012 Jun; 49(6):486-8. PubMed ID: 22796691
[TBL] [Abstract][Full Text] [Related]
19. The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetes.
Holstein JD; Kovacs P; Patzer O; Stumvoll M; Holstein A
Pharmacogenomics; 2012 Jan; 13(1):5-7; author reply 9-10. PubMed ID: 22176616
[No Abstract] [Full Text] [Related]
20. [Glimepiride].
Nakamura N
Nihon Rinsho; 2002 Sep; 60 Suppl 9():351-6. PubMed ID: 12387017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
